BKV LT-ag peptide LLLIWFRPV (HLA-B*0201)

IBA Lifescience Kontakt z doradcą
Single peptide synthesized as presented by the MHC class I allele
BKV LT-ag peptide LLLIWFRPV (HLA-B*0201)

BKV LT-ag peptide LLLIWFRPV (HLA-B*0201) is a single peptide for stimulation of T cells. The peptide from BK polyomavirus (BKV) large tumor antigen (LT-ag) is synthesized as it is presented by the MHC class I HLA-B*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.

Specifications

  • Form: Lyophilized powder
  • Peptide Sequence: LLLIWFRPV
  • Possible Application: T cell stimulation
  • Purity: > 85%
  • Sterility: Sterile

Podobne produkty

CD3/CD28 Streptamer® Kit, human

CD3/CD28 Streptamer® Kit, human

IBA Lifescience
Więcej
Prame peptide VLDGLDVLL (HLA-A*0201)

Prame peptide VLDGLDVLL (HLA-A*0201)

IBA Lifescience
Więcej
WT1 peptide RMFPNAPYL (HLA-A*0201)

WT1 peptide RMFPNAPYL (HLA-A*0201)

IBA Lifescience
Więcej